Anzeige
Mehr »
Freitag, 12.12.2025 - Börsentäglich über 12.000 News
News von heute Morgen: Noch bevor der Markt erwacht, könnte es jetzt explosiv werden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoTD Cowen raises Globe Life stock price target to $199 on growth outlook
DoTD Cowen reaffirms Boston Scientific stock rating with $115 price target
DoTD Cowen raises Royalty Pharma stock price target on growth outlook
DoChowChow Cloud reports unusual trading activity in its shares
DoBank Midwest selects Raymond James to support investment program
DoNatera stock rating reiterated at Buy by TD Cowen on solid momentum
DoCiena Q4 2025 slides: revenue jumps 20%, cloud provider growth accelerates
DoWood Group chair Roy Franklin to remain until acquisition closes
DoCindrigo Holdings sets AGM date as commercial chief steps down
DoCEPS confirms negotiations for potential ICA Group disposal
DoiShares Digital Assets AG issues new tranche of bitcoin ETP securities
DoSEGG Media raises $2.5 million to fund acquisition plans
DoBlack Titan unveils third pillar of DAT+ strategy focusing on token utility
DoVisa appoints Najada Kumbuli as president of Visa Foundation
DoTD Cowen reaffirms Ryan Specialty Group stock rating with 46% upside
DoTD Cowen raises Chewy stock price target to $48 on strong Q3 results
DoMicron Technology stock price target maintained at $275 by TD Cowen
DoGE HealthCare price target raised to $105 from $95 at Jefferies on positive outlook
DoCrowdStrike stock upgraded to Buy at Freedom Capital on cybersecurity demand
DoBMO Capital reiterates Outperform rating on United Natural Foods stock
DoBMO Capital reiterates Outperform rating on SailPoint Technologies stock
DoOxford Industries stock price target lowered to $35 at Truist on soft outlook
DoTruist Securities raises Fulcrum Therapeutics stock price target on positive sickle cell data
DoZscaler stock maintains Buy rating at Freedom Capital on strong Q1 results
DoKratos Defense stock rises as Boom Supersonic enters power market